Why Virtualize Clinical Trials?
About 10 percent of new drugs complete the first phase of a clinical trial but patient participation drops by 30
Read moreAbout 10 percent of new drugs complete the first phase of a clinical trial but patient participation drops by 30
Read moreClinical trials are often unsuccessful or incomplete due to the huge costs and other issues associated with recruitment and keeping
Read morePrescreening potential subjects in oncology clinical trials is one of the most significant limiting factors in identifying eligible participants which
Read moreThe goals of drug development process involves supporting all stakeholders in improving patient care, addressing challenges associated with financial sustainability
Read moreOne of the leading emerging Pharmaceutical markets, India has completed its long anticipated medical device guidelines. The guidelines are set
Read moreParexel’s expanded Managed Access Program allows bio-pharmaceutical organizations to offer compassionate access to patients as the sector faces a growing
Read moreAfter 6 years US FDA finalized Guidance on Assessing Abuse Potential of Drugs on 18th January 2017. The first draft
Read moreA protein that regulates cell division also has an essential role in switching genes on / off, researchers have identified,
Read moreImmunotherapy has confirmed to be efficient against many serious conditions. But to treat problems in the brain, the antibodies must
Read moreInvestigators from the University of Helsinki have revealed that 3 anti-influenza compounds successfully inhibit Zika virus infection in human cells.
Read more